JPS6354681B2 - - Google Patents

Info

Publication number: JPS6354681B2
Authority: JP; Japan
Prior art keywords: tissue; transplantation; organs; freezing; tissues
Prior art date: 1979-07-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

JP54087917A

Other languages

English (en)

Japanese (ja)

Other versions

JPS5612317A (en

Inventor

Kenji Sato

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

YAMAKAWA BOEKI KK

Original Assignee

YAMAKAWA BOEKI KK

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1979-07-10

Filing date

1979-07-10

Publication date

1988-10-28

1979-07-10 Application filed by YAMAKAWA BOEKI KK filed Critical YAMAKAWA BOEKI KK

1979-07-10 Priority to JP8791779A priority Critical patent/JPS5612317A/ja

1981-02-06 Publication of JPS5612317A publication Critical patent/JPS5612317A/ja

1988-10-28 Publication of JPS6354681B2 publication Critical patent/JPS6354681B2/ja

Status Granted legal-status Critical Current

Links

238000000034 method Methods 0.000 claims description 16
238000002054 transplantation Methods 0.000 claims description 15
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
210000000056 organ Anatomy 0.000 claims description 6
239000000243 solution Substances 0.000 claims description 6
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 4
239000007853 buffer solution Substances 0.000 claims description 4
210000004907 gland Anatomy 0.000 claims description 4
210000002826 placenta Anatomy 0.000 claims description 4
241000283690 Bos taurus Species 0.000 claims description 3
241001494479 Pecora Species 0.000 claims description 3
239000000443 aerosol Substances 0.000 claims description 2
210000003754 fetus Anatomy 0.000 claims description 2
239000011261 inert gas Substances 0.000 claims description 2
238000010255 intramuscular injection Methods 0.000 claims description 2
239000007927 intramuscular injection Substances 0.000 claims description 2
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 2
239000001509 sodium citrate Substances 0.000 claims description 2
239000000725 suspension Substances 0.000 claims description 2
241000282887 Suidae Species 0.000 claims 1
230000001850 reproductive effect Effects 0.000 claims 1
210000001519 tissue Anatomy 0.000 description 72
238000007710 freezing Methods 0.000 description 13
230000008014 freezing Effects 0.000 description 13
230000004071 biological effect Effects 0.000 description 9
235000018102 proteins Nutrition 0.000 description 9
102000004169 proteins and genes Human genes 0.000 description 9
108090000623 proteins and genes Proteins 0.000 description 9
230000000694 effects Effects 0.000 description 6
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
239000013078 crystal Substances 0.000 description 5
239000000203 mixture Substances 0.000 description 5
238000011282 treatment Methods 0.000 description 5
238000009423 ventilation Methods 0.000 description 5
XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
210000004369 blood Anatomy 0.000 description 4
239000008280 blood Substances 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
239000007789 gas Substances 0.000 description 4
230000008105 immune reaction Effects 0.000 description 4
241000282412 Homo Species 0.000 description 3
241001465754 Metazoa Species 0.000 description 3
230000005779 cell damage Effects 0.000 description 3
208000037887 cell injury Diseases 0.000 description 3
239000000470 constituent Substances 0.000 description 3
230000034994 death Effects 0.000 description 3
238000004925 denaturation Methods 0.000 description 3
230000036425 denaturation Effects 0.000 description 3
238000010438 heat treatment Methods 0.000 description 3
238000000265 homogenisation Methods 0.000 description 3
210000003734 kidney Anatomy 0.000 description 3
229910001220 stainless steel Inorganic materials 0.000 description 3
239000010935 stainless steel Substances 0.000 description 3
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
102000004506 Blood Proteins Human genes 0.000 description 2
108010017384 Blood Proteins Proteins 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
210000004100 adrenal gland Anatomy 0.000 description 2
230000000735 allogeneic effect Effects 0.000 description 2
239000003708 ampul Substances 0.000 description 2
230000000890 antigenic effect Effects 0.000 description 2
229910052786 argon Inorganic materials 0.000 description 2
210000000988 bone and bone Anatomy 0.000 description 2
239000006285 cell suspension Substances 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
239000000112 cooling gas Substances 0.000 description 2
230000007850 degeneration Effects 0.000 description 2
235000019441 ethanol Nutrition 0.000 description 2
238000000605 extraction Methods 0.000 description 2
210000003195 fascia Anatomy 0.000 description 2
238000004108 freeze drying Methods 0.000 description 2
230000006870 function Effects 0.000 description 2
210000002216 heart Anatomy 0.000 description 2
229960003444 immunosuppressant agent Drugs 0.000 description 2
239000003018 immunosuppressive agent Substances 0.000 description 2
210000004185 liver Anatomy 0.000 description 2
239000002245 particle Substances 0.000 description 2
239000002994 raw material Substances 0.000 description 2
239000003507 refrigerant Substances 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
239000000126 substance Substances 0.000 description 2
238000002560 therapeutic procedure Methods 0.000 description 2
102000009027 Albumins Human genes 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
206010002091 Anaesthesia Diseases 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
208000035404 Autolysis Diseases 0.000 description 1
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
206010057248 Cell death Diseases 0.000 description 1
102000003914 Cholinesterases Human genes 0.000 description 1
108090000322 Cholinesterases Proteins 0.000 description 1
208000035240 Disease Resistance Diseases 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
102000006395 Globulins Human genes 0.000 description 1
108010044091 Globulins Proteins 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
229920002527 Glycogen Polymers 0.000 description 1
239000012981 Hank's balanced salt solution Substances 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
235000019687 Lamb Nutrition 0.000 description 1
241000283903 Ovis aries Species 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
206010070834 Sensitisation Diseases 0.000 description 1
241000282898 Sus scrofa Species 0.000 description 1
NYTOUQBROMCLBJ-UHFFFAOYSA-N Tetranitromethane Chemical compound [O-][N+](=O)C([N+]([O-])=O)([N+]([O-])=O)[N+]([O-])=O NYTOUQBROMCLBJ-UHFFFAOYSA-N 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
238000012084 abdominal surgery Methods 0.000 description 1
206010000269 abscess Diseases 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
125000000539 amino acid group Chemical group 0.000 description 1
230000037005 anaesthesia Effects 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
235000011089 carbon dioxide Nutrition 0.000 description 1
229940048961 cholinesterase Drugs 0.000 description 1
238000001816 cooling Methods 0.000 description 1
238000012258 culturing Methods 0.000 description 1
229960003067 cystine Drugs 0.000 description 1
230000000093 cytochemical effect Effects 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000006837 decompression Effects 0.000 description 1
230000018044 dehydration Effects 0.000 description 1
238000006297 dehydration reaction Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
239000003814 drug Substances 0.000 description 1
229940088598 enzyme Drugs 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
230000003631 expected effect Effects 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
235000013305 food Nutrition 0.000 description 1
230000002431 foraging effect Effects 0.000 description 1
238000012812 general test Methods 0.000 description 1
239000011521 glass Substances 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
229940096919 glycogen Drugs 0.000 description 1
MAHXCOMHJBHBGO-RTKIROINSA-N hematoxin Chemical compound C12=CC(O)=C(O)C=C2C[C@]2(O)[C@H](OC)C11C=CC(=O)C(O)=C1OC2 MAHXCOMHJBHBGO-RTKIROINSA-N 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
230000036039 immunity Effects 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
208000032839 leukemia Diseases 0.000 description 1
229940057995 liquid paraffin Drugs 0.000 description 1
230000007774 longterm Effects 0.000 description 1
239000000463 material Substances 0.000 description 1
238000000691 measurement method Methods 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
-1 nucleic acid salts Chemical class 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
230000003071 parasitic effect Effects 0.000 description 1
239000012466 permeate Substances 0.000 description 1
230000003285 pharmacodynamic effect Effects 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
239000000047 product Substances 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
235000019833 protease Nutrition 0.000 description 1
238000005057 refrigeration Methods 0.000 description 1
238000011160 research Methods 0.000 description 1
230000028043 self proteolysis Effects 0.000 description 1
230000008313 sensitization Effects 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
230000035939 shock Effects 0.000 description 1
239000010802 sludge Substances 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
238000000870 ultraviolet spectroscopy Methods 0.000 description 1
210000001113 umbilicus Anatomy 0.000 description 1
210000004291 uterus Anatomy 0.000 description 1
229960005486 vaccine Drugs 0.000 description 1
235000013311 vegetables Nutrition 0.000 description 1

Landscapes

Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

JP8791779A 1979-07-10 1979-07-10 Retention of fresh tissue transplantable by injection Granted JPS5612317A (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
JP8791779A JPS5612317A (en)	1979-07-10	1979-07-10	Retention of fresh tissue transplantable by injection

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP8791779A JPS5612317A (en)	1979-07-10	1979-07-10	Retention of fresh tissue transplantable by injection

Publications (2)

Publication Number	Publication Date
JPS5612317A JPS5612317A (en)	1981-02-06
JPS6354681B2 true JPS6354681B2 (fr)	1988-10-28

Family

ID=13928266

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP8791779A Granted JPS5612317A (en)	1979-07-10	1979-07-10	Retention of fresh tissue transplantable by injection

Country Status (1)

Country	Link
JP (1)	JPS5612317A (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5059518A (en) *	1988-10-20	1991-10-22	Coulter Corporation	Stabilized lyophilized mammalian cells and method of making same
JPH0637707B2 (ja) *	1988-12-26	1994-05-18	住友金属工業株式会社	耐フレーキング性に優れた多層めっき鋼板
JPH05214549A (ja) *	1992-02-05	1993-08-24	Murata Mfg Co Ltd	無電解ビスマスめっき膜の形成方法および無電解ビスマスめっき浴

1979
- 1979-07-10 JP JP8791779A patent/JPS5612317A/ja active Granted

Also Published As

Publication number	Publication date
JPS5612317A (en)	1981-02-06

Publication	Publication Date	Title
JP6850360B2 (ja)	2021-03-31	臨床使用可能な細胞凍結保存液
JP4942896B2 (ja)	2012-05-30	新規な凍結試料の加温方法
KR100779812B1 (ko)	2007-11-28	비-조혈 조직으로부터의 비-배아세포의 보존
CN1119599C (zh)	2003-08-27	培养皮肤组织相同物的冷藏和贮存的方法以及设备
US6284285B1 (en)	2001-09-04	Tissue repair promoting composition
US4473552A (en)	1984-09-25	Anaerobic method for preserving whole blood, tissue and components containing living mammalian cells
US3303662A (en)	1967-02-14	Process for cell preservation
US8628960B2 (en)	2014-01-14	Desiccated biologics and methods of preparing the same
JP2005502712A5 (fr)	2006-08-17
CA2719806A1 (fr)	2009-10-01	Procede, systeme et appareil pour la collecte, le stockage, le transport et le placement en banque de sang de tissu natal
CN110583622A (zh)	2019-12-20	一种t细胞无血清冻存液及其使用方法
JP2024026645A (ja)	2024-02-28	病原体減少血小板組成物および関連方法
US4374830A (en)	1983-02-22	Platelet aggregating material from equine arterial tissue
CN108812643B (zh)	2021-09-21	人胎盘绒毛膜组织的制备冻存方法和应用
CN113729006A (zh)	2021-12-03	一种猪种种质资源的快速保存方法
JP6412696B2 (ja)	2018-10-24	血清調製方法および器具
US20160287749A1 (en)	2016-10-06	Reconstituted amniotic membrane-amniotic fluid combination tissue graft
EP0061277B1 (fr)	1986-09-03	Procédé anaérobie pour conserver du sang complet, des tissus ou des produits contenant des cellules vivantes de mammifères
Hendry et al.	1968	Twenty-four-hour storage of kidneys
CN114027294B (zh)	2022-11-29	一种免疫细胞冻存液及免疫细胞冻存方法
CN108812641B (zh)	2021-07-23	人胎盘绒毛组织的制备冻存方法和应用
NL2034495B1 (en)	2025-01-07	Stem cell cryopreservation protective agent, preparation method, and application thereof
Doğan et al.	2023	Fundamental principles of cryopreservation and stem cell banking
TWI640630B (zh)	2018-11-11	不具胎牛血清之細胞冷凍保存組合物
AU2022209856A1 (en)	2023-08-17	Methods for optimizing reproductive tissue derived cell yield and viability for clinical applications